Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)
Langley, Ruth E, Dr, Cafferty, Fay H, PhD, Alhasso, Abdulla A, FRCR, Rosen, Stuart D, MD, Sundaram, Subramanian Kanaga, FRCS, Freeman, Suzanne C, MSc, Pollock, Philip, MRes, Jinks, Rachel C, PhD, Godsland, Ian F, PhD, Kockelbergh, Roger, FRCS(Urol), Clarke, Noel W, Prof, Kynaston, Howard G, Prof, Parmar, Mahesh KB, Prof, Abel, Paul D, Prof
Published in The lancet oncology (01.04.2013)
Published in The lancet oncology (01.04.2013)
Get full text
Journal Article